Steminent Biotherapeutics Inc.

Steminent Biotherapeutics is a biopharmaceutical company in Taiwan and the United States. It provides Stemchymal, a cell therapy product for the treatment of neurodegenerative diseases, including spinocerebellar ataxia and huntington's disease.

Its portfolio also includes tissue regeneration, such as osteoarthritis, and acute syndromes consisting acute respiratory distress syndrome, liver failure, and ischemic stoke. Founded in 2009, the company is based in Taipei, Taiwan.